Pancreatic Cancer Research

ResearcherQiqihar Medical UniversityNo recent work listed

Shi Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2289-9160; OpenAlex author ID A5057323286. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Comment on "Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression". Last author DOI 10.4251/wjgo.v15.i2.368↗
  2. Comment on "Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer". Last author DOI 10.3748/wjg.v28.i44.6310↗
  3. Survival outcome after stereotactic body radiotherapy for locally advanced and borderline resectable pancreatic cancer: A systematic review and meta-analysis. Co-author DOI 10.1016/j.tranon.2021.101139↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ying Liu · 1 shared paper, 2023 · strength 0.31
  2. Jian Yang · 1 shared paper, 2023 · strength 0.31
  3. Jian Yang · 1 shared paper, 2022 · strength 0.26
  4. Changming Ma · 1 shared paper, 2021 · strength 0.14
  5. Min Li · 1 shared paper, 2021 · strength 0.14
  6. Jian Yang · 1 shared paper, 2021 · strength 0.14
  7. Ying Liu · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.